Humana Inc. $HUM Stake Lifted by Investment Management Corp of Ontario

Investment Management Corp of Ontario boosted its position in Humana Inc. (NYSE:HUM) by 205.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,375 shares of the insurance provider’s stock after purchasing an additional 6,979 shares during the period. Investment Management Corp of Ontario’s holdings in Humana were worth $2,536,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Revolve Wealth Partners LLC bought a new stake in Humana in the fourth quarter worth about $202,000. Zions Bancorporation National Association UT bought a new stake in Humana during the first quarter worth approximately $37,000. Townsquare Capital LLC boosted its holdings in Humana by 2.8% during the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider’s stock worth $597,000 after buying an additional 61 shares in the last quarter. Public Sector Pension Investment Board grew its position in Humana by 8.9% in the first quarter. Public Sector Pension Investment Board now owns 16,533 shares of the insurance provider’s stock worth $4,375,000 after buying an additional 1,352 shares during the last quarter. Finally, HighTower Advisors LLC increased its holdings in shares of Humana by 8.3% in the first quarter. HighTower Advisors LLC now owns 7,630 shares of the insurance provider’s stock valued at $2,019,000 after buying an additional 583 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Up 2.4%

Shares of NYSE:HUM opened at $256.29 on Thursday. The company has a market capitalization of $30.82 billion, a PE ratio of 24.02, a P/E/G ratio of 1.47 and a beta of 0.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The company’s fifty day moving average is $262.53 and its 200-day moving average is $257.71. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company’s revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the business posted $4.16 earnings per share. Equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is presently 33.18%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Truist Financial decreased their price target on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Barclays dropped their target price on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 25th. Mizuho upped their price target on Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Finally, Wolfe Research decreased their target price on Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a research report on Thursday, November 20th. Nine analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $296.84.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.